During this process, CD137 is trogocytically transferred from cancer cells to CD137L on APCs, resulting in the endocytosis of the receptor-ligand complex and thus impairing the CD137L-mediated costimulatory activity of APCs 19-21. This evidence concerns the gene TNFRSF9 and cancer.